![]() |
市場調查報告書
商品編碼
1442591
全球眼壓計市場評估:按類型、技術、模式、最終用戶、地區、機會、預測(2017-2031)Tonometer Market Assessment, By Type, By Technology, By Modality, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球眼壓計市場規模預計將從 2023 年的 3.038 億美元成長到 2031 年的 4.8714 億美元,預測期內複合年增長率為 6.08%。
全球眼壓計市場的成長是由青光眼等眼部疾病的日益普及、技術的快速進步以及眼科產業的顯著成長所推動的。 政府支持、政策和計劃的增加、領先公司增加開發高效眼壓計的投資、支持性監管框架以及相關公司之間的合資企業等因素正在推動市場的成長。
由於全球青光眼盛行率不斷上升,全球眼壓計市場持續強勁成長。 由於青光眼會導致不可逆轉的視力喪失,因此早期發現這種疾病是醫療保健提供者的首要任務。 眼壓計在檢測青光眼和評估治療效果方面發揮重要作用。 隨著青光眼病例的不斷增加,對眼壓計的需求不斷增加,許多領先公司在其眼科醫療產品組合中不斷推出創新、高效的眼壓計,這正在推動全球眼壓計市場的成長。
用於改善眼部檢查和青光眼診斷過程的先進、精密的數位眼壓計和手持式眼壓計等技術進步也對市場成長產生正面影響。 有利的監管框架以及政府透過資助研發以及促進青光眼篩檢(尤其是偏遠地區人群)的政策和計劃不斷增加的支持,也導致了全球眼壓計市場的成長。 此外,併購、公司之間的合作協議以及新創公司的進入等合作活動的增加正在進一步推動全球眼壓計市場的發展。
例如,BVS Sight Inc. 是一家開發眼壓計和隱形眼鏡等眼科設備的新創公司。 該公司是 Boomerang Ventures Studio、普渡大學鑄造廠和普渡大學研究基金會技術辦公室合作成立的。 此類新創公司的不斷進入將帶來該行業的技術進步,並帶動全球眼壓計市場的成長。
北美佔較大市佔率
北美憑藉其強大的醫療基礎設施和技術先進的青光眼檢測設備(例如數位眼壓計)在全球眼壓計市場中佔據主導地位。 美國青光眼疾病盛行率的不斷上升是加速該地區市場成長的關鍵因素。 例如,根據 2023 年青光眼報告,美國約有 300 萬人患有青光眼疾病,而且這項盛行率預計未來還會增加。 大眾敏銳地意識到早期診斷和篩檢青光眼在預防不可逆轉的視力喪失方面的潛在好處,從而產生了對眼壓計的巨大需求。 此外,不斷增加的研發計劃、大公司加大對推出創新眼壓計的投資,以及 Reichert, Inc. 和 Kowa American Corporation 等全球領先企業的出現,都進一步加速了對眼壓計的需求。
本報告調查了全球眼壓計市場,提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素分析。我們編制了案例研究、競爭格局、主要公司的簡介等等。
Global tonometer market is projected to witness a CAGR of 6.08% during the forecast period 2024-2031, growing from USD 303.8 million in 2023 to USD 487.14 million in 2031. Growth in the global tonometer market is driven by an increase in the prevalence of eye diseases such as glaucoma, rapid technological advancements, and significant growth in the ophthalmic industry. Increased governmental support, policies, and programs, increased investments by leading players to develop highly efficient tonometer, along with supportive regulatory framework and collaborative ventures between the related firms further promote the growth of the global tonometer market.
The global tonometer market is consistently undergoing robust growth due to an increase in the prevalence of glaucoma worldwide. As glaucoma causes irreversible vision loss, the early detection of this disease is a top priority for healthcare providers. Tonometers play a crucial role in detecting glaucoma and assessing the effectiveness of provided treatment among the population affected by this disease. With the growing cases of glaucoma, there is an increased demand for tonometers due to which many leading players are continuously involved in launching innovative and efficient tonometers in their ophthalmic care product portfolio, which is further propelling the growth of the global tonometer market.
Technological advancements, such as the development of highly advanced and sophisticated digital and handheld tonometers, to improve eye examination and glaucoma diagnosis processes are positively influencing the market growth. A favorable regulatory framework and increased governmental support through funds for research and development and policies and programs to accelerate glaucoma screening among the population, especially in remote areas, have led to the growth of the global tonometer market. Moreover, increased collaboration activities, such as mergers and acquisitions, partnership agreements between the companies, and the entrance of start-ups in this market, further propel the global tonometer market.
For instance, BVS Sight Inc., is a start-up that develops ophthalmic devices such as tonometers and contact lenses. The company was created through a partnership between Boomerang Ventures Studio, Purdue Foundry, and the Purdue Research Foundation Office of Technology. These consistent entrances of start-ups bring technological advancements in the industry and lead to growth in the global tonometer market.
Increasing Prevalence of Glaucoma
The demand for tonometers is increasing significantly due to the rising number of glaucoma cases worldwide. Glaucoma is the second leading cause of blindness globally as it causes irreversible vision loss. A tonometer is widely used to measure intraocular pressure (IOP) and helps in detecting changes in eye pressure, which further assists in the diagnosis of glaucoma. According to an article published in the Journal of Clinical Medicine, the prevalence of glaucoma is rapidly increasing, and it is expected that by the year 2040, the number of people affected by glaucoma will increase to 112 million. Due to this growing prevalence, leading companies are frequently involved in investments to enhance research and development to bring technologically advanced and efficient tonometers that can assist in accurate and timely diagnosis of this disease. Moreover, governments from all over the world are implementing policies and programs to provide eye health screening programs to accelerate the early detection process of glaucoma. Due to this, the demand for tonometers across the world is increasing significantly.
Technological Advancements
Technological advancements in developing advanced tonometers play a crucial role in escalating the growth of the global tonometer market. Technological advancements, such as the development of highly efficient, compact, and sophisticated tonometers, that can lead to painless eye screening are boosting the growth of the global tonometer market. Additionally, leading players in the market are continuously involved in research and development to bring more technically advanced products into their product portfolio that can play a major role in combating the growing prevalence of glaucoma among the global population. For instance, in January 2024, DevelopAll Inc., which is a New York-based firm, announced the launch of its latest innovative product the "Diaton digital tonometer". This latest launch is a compact, handheld trans-palpebral and transscleral tonometry instrument that is expected to bring significant advancements in the ophthalmic industry, as it addresses the limitations of traditional IOP measurement techniques and measures the IOP through the eyelid, bypassing the cornea, which, in turn, improves accuracy in glaucoma screening and avoids keratoconus condition. Diaton digital tonometer doesn't need anesthesia, sterilization, or any consumables, hence enhancing patients' comfort. These innovative technological advancements are accelerating the global tonometer market growth.
Increased Demand for Indirect Tonometers
Among the different types of tonometers, indirect tonometers are expected to show significant growth in the global tonometer market. Indirect tonometers don't require anesthesia as there is no direct contact of the device with the cornea for measuring the IOP values. As this process is painless, it improves patient comfort and leads to increased demand for indirect tonometers as compared to direct tonometers. Due to this, many companies are focusing on developing indirect tonometers with enhanced efficiency, which is further escalating the growth of the global tonometer market. For instance, in April 2023, NIDEK CO., LTD., which is a global leader in ophthalmic care devices, announced the successful launch of the "NT-1/1e indirect tonometer". This tonometer provides complete automated measurements with enhanced patient safety and consists of voice guidance that facilitates smooth and correct measurement of IOP values. These innovative developments by key market players are accelerating the growth of the global tonometer market.
Increased Demand for Handheld Tonometers
Among the modality segment, the application of handheld tonometer is expected to show tremendous growth in the forecasted period. Handheld tonometers have a higher demand compared to desktop tonometers as they offer portability and ease of use. As it is convenient to use and portable by nature, these are widely used in screening programs in remote areas. Due to its wide areas of application and growing demand among healthcare providers, leading players are involved in developing innovative and efficient handheld tonometers in their product portfolio. For instance, in May 2023, Reichert Technologies, which is a global leader in manufacturing diagnostic devices for eye care, announced the launch of the "Tono-Vera Tonometer". This consists of an "actiView positioning system", that helps in faster, more reliable, and accurate IOP measurements. This new tonometer uses rebound tonometer technology for measuring IOP and doesn't require the use of topical anesthetic. With these efficient and innovative launches by the leading players, the global tonometer market is expected to flourish in the future.
North America Holds Significant Market Share
North America dominates the global tonometer market, due to its robust healthcare infrastructure and availability of technologically advanced glaucoma detection devices such as digital tonometer. The growing prevalence of glaucoma disease in the United States is acting as a crucial factor in accelerating the market growth in the region. For instance, the "2023 Glaucoma Report" states that around three million people in the United States are affected by glaucoma disease and this prevalence is expected to rise in the future as well. The public is highly aware regarding the potential benefits of early diagnosis and screening for glaucoma to prevent irreversible vision loss among the population, which is creating a substantial demand for tonometers. Additionally, increased research and development initiatives, along with increased investments by leading players in launching innovative tonometers and the presence of global leaders like Reichert, Inc. and Kowa American Corporation, further accelerates the demand for the global tonometer market.
Future Market Scenario (2024 - 2031F)
The global tonometer market is expected to grow in the future, primarily due to the rapidly increasing prevalence of glaucoma worldwide. The expanding ophthalmic industry, growing demand for handheld and indirect tonometers, technological advancements, and increased investments by public and private organizations in developing highly efficient tonometers to cater to evolving healthcare needs are anticipated to accelerate the market growth. Moreover, collaborative ventures, such as mergers and acquisitions, partnerships, frequent product launches, and increased FDA approvals by regulatory bodies, further lead to the growth of the global tonometer market. For Instance, in March 2022, Icare USA, which is a leading ophthalmic technology company, announced that it had received FDA approval for its latest product "iCare HOME2". This is a next-generation self-tonometer, which has been developed for glaucoma patients to enhance remote monitoring. These frequent product launches, along with supportive regulatory frameworks, are expected to escalate the growth of this market in the forecasted period.
Key Players Landscape and Outlook
In the tonometer market, both public and private firms are consistently forming strategic partnerships and distribution agreements. These agreements play a crucial role in accelerating the global tonometer market's expansion. Such partnerships enable firms to gain in-depth insights into the market, strategically use each other's resources, markets, and technologies, and invest in research and development activities to bring innovation and advancements to the market. Distribution agreements allow companies to expand their market presence globally. These collaborative initiatives promote innovation and expertise in product development, which improves patient health outcomes and contributes to the enduring and robust growth of the global tonometer market.
For instance, in February 2023, NIDEK CO., LTD., which is a global leader in developing advanced ophthalmic devices, such as tonometers, announced a strategic partnership with HOYA Vision Care, which is a pioneer in developing innovative optical solutions. This strategic partnership will enable eye care professionals to gain access to highly efficient and innovative optical instruments, such as tonometers, to provide quality diagnostics facilities to the patient. These consistent collaborative ventures further support elevating the market globally.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023